Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Core EBITDA Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 38.76-7.1420.1417.5458.34

What is the latest Core EBITDA Growth ratio of MANKIND PHARMA ?

The latest Core EBITDA Growth ratio of MANKIND PHARMA is 38.76 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202438.76
Mar2023-7.14
Mar202220.14
Mar202117.54
Mar202058.34

How is Core EBITDA Growth of MANKIND PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2024 38.76
Positive
Mar2023 -7.14
Negative
Mar2022 20.14
14.82
Mar2021 17.54
-69.93
Mar2020 58.34 -

Other Financial Ratios of MANKIND PHARMA


Compare Core EBITDA Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,303.1 Cr 1.1% -7% 9.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.1%

-7%

9.7%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses